Dihexa is a powerful nootropic peptide, known as a "neurogenic wonder-drug," developed by researchers from Washington State University. It is designed to enhance cognitive function and facilitate the repair of brain damage. Dihexa functions by potentiating the activity of hepatocyte growth factor (HGF) at its receptor, c-Met. This interaction is pivotal for neurogenesis and synaptic plasticity, making Dihexa significantly effective in restoring mental capabilities and reversing cognitive decline. Its potency is reported to surpass that of brain-derived neurotrophic factor (BDNF) by a factor of ten million, highlighting its potential as a transformative agent in neurotherapeutic interventions.